NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) to Present At the LD MICRO Invitational Conference

EMERYVILLE, Calif., Sept. 21, 2011 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide(R) compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections, announces that Ron Najafi, Ph.D., Chairman and Chief Executive Officer, will present at the LD MICRO Invitational Conference on Thursday, September 22nd, 2011 at the Luxe Sunset Bel Air in Los Angeles. The presentation is scheduled for 1:00 PM PDT / 4:00 PM EDT.